Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating induction therapy combining an intercalated tyrosine kinase inhibitor with chemotherapy for NSCLC pati…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating NK cell infusion combined with chemotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating icotinib plus dihydroaremisinin (DHA) in EGFR-positive non-small cell lung cancer with adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC [Phase 2]
Phase 2 clinical trial evaluating metronomic low-dose treosulfan, pioglitazone, and clarithromycin versus standard treatment in non-small ce…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update on maintenance therapies for advanced non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases [Phase 2]
Phase 2 trial update of apatinib plus docetaxel for advanced non-squamous non-small cell lung cancer with bone metastases.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation [Phase 2]
Phase 2 trial update evaluating continuing gefitinib after progression in EGFR-mutated non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer [NA]
Clinical trial evaluating genetic sequencing-informed targeted therapy for stage IIIB-IV non-small cell lung cancer has been terminated with…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update of Tarceva (OSI-774) in stage III/IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [NA]
This terminated clinical trial evaluated stereotactic radiosurgery for stage I/II non-small cell lung cancer and had its results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients [Phase 1, Phase 2]
A clinical trial update evaluating WX-0593 in advanced solid tumors and non-small cell lung cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 2]
A Phase 2 global trial evaluating durvalumab (MEDI4736) in locally advanced or metastatic non-small cell lung cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC [Phase 2]
Phase 2 clinical trial update evaluating apatinib for EGFR T790M-negative non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial assessing efficacy and safety of oral BIBF 1120 ES in advanced non-small-cell lung cancer completed.
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLC [Phase 2]
Phase 2 trial update evaluating pembrolizumab as maintenance therapy in treated patients with unresectable stage III non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer [Phase 2]
Phase 2 trial update for S-588410 after adjuvant chemotherapy in completely resected non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer [NA]
Trial update on safety of LEAD radiotherapy plus chemoradiation in bulky stage III non-small cell lung cancer; the study was terminated with…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy [Phase 2]
This document summarizes a completed Phase II trial evaluating cisplatin-docetaxel induction followed by concurrent 3-D conformal radiothera…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib [Phase 2]
Phase 2 trial evaluating erlotinib in combination with BKM120 in advanced non-small cell lung cancer patients previously sensitive to erloti…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of apatinib with radiotherapy for brain metastases in patients with non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluated hypofractionated proton beam radiation therapy in combination with paclitaxel and carboplatin for stage II-III non…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC [Phase 2]
This Phase 2 trial investigates hippocampus-sparing whole-brain radiotherapy with a simultaneous integrated boost for brain metastases from …
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer. [Phase 2]
Phase 2 trial evaluating dabrafenib alone or in combination with trametinib for BRAF V600E metastatic non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) [Phase 2]
Phase 2 trial comparing stereotactic body radiotherapy (SBRT) with stereotactic body proton therapy (SBPT) for non-small cell lung cancer wa…
-
CLINICAL_TRIALS withdrawal · 2017-12-06Clinical Trial Update: Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC [Phase 2]
This Phase 2 trial of durvalumab plus tremelimumab as adjuvant therapy for resected non-small cell lung cancer has been withdrawn.